Based on RNA sequencing (RNA-seq) data from patients, MDS2 is overexpressed in CLL versus normal cells and also differentially expressed between two experimentally determined CLL subgroups14. This evidence concerns the gene MDS2 and B-cell chronic lymphocytic leukemia.